Frontiers in peptide–MHC class II multimer technology

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2002 English Publisher:Springer Science and Business Media LLCJournal:Nature Immunology, volume 3, pages 887-889 (issn: 1529-2908, eissn: 1529-2916,

Copyright policy )

Authors: Charles J. Hackett; Opendra K. Sharma;

doi: 10.1038/ni1002-887

Frontiers in peptide–MHC class II multimer technology

- Summary
- Metrics

Abstract

Although tetramer technology has been wildly successful for examination of MHC class I–recognizing T cells, the same hasn't been true for MHC class II reagents. A recent workshop at the US National Institute of Allergy and Infectious Diseases was convened to address this.

Related Organizations

National Institute of Health
Pakistan

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	23
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%